RJT
LLY icon

Raymond James Trust’s Eli Lilly LLY Stock Holding History

Raymond James Trust’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$31M Buy
34,943
+240
+0.7% +$216K 0.67% 30
2024
Q2 		$31.4M Buy
34,703
+1,739
+5% +$1.39M 0.74% 28
2024
Q1 		$25.6M Buy
32,964
+438
+1% +$312K 0.62% 36
2023
Q4 		$19M Buy
32,526
+514
+2% +$300K 0.5% 45
2023
Q3 		$17.2M Buy
32,012
+2,238
+8% +$1.15M 0.51% 48
2023
Q2 		$14M Sell
29,774
-5,164
-15% -$2.17M 0.4% 60
2023
Q1 		$12M Buy
34,938
+4,172
+14% +$1.41M 0.38% 63
2022
Q4 		$11.3M Sell
30,766
-655
-2% -$232K 0.38% 63
2022
Q3 		$10.2M Buy
31,421
+177
+0.6% +$56.1K 0.38% 63
2022
Q2 		$10.1M Sell
31,244
-948
-3% -$285K 0.36% 64
2022
Q1 		$9.22M Sell
32,192
-243
-0.7% -$62.5K 0.28% 81
2021
Q4 		$8.96M Sell
32,435
-5,026
-13% -$1.27M 0.27% 85
2021
Q3 		$8.65M Sell
37,461
-5,664
-13% -$1.4M 0.29% 82
2021
Q2 		$9.9M Buy
43,125
+344
+0.8% +$69.1K 0.33% 71
2021
Q1 		$7.99M Sell
42,781
-4,470
-9% -$874K 0.28% 86
2020
Q4 		$7.98M Sell
47,251
-1,956
-4% -$292K 0.31% 79
2020
Q3 		$7.28M Sell
49,207
-47
-0.1% -$7.27K 0.31% 73
2020
Q2 		$8.09M Sell
49,254
-204
-0.4% -$31.3K 0.39% 63
2020
Q1 		$6.86M Buy
49,458
+3,981
+9% +$547K 0.41% 61
2019
Q4 		$5.98M Sell
45,477
-3,365
-7% -$390K 0.29% 82
2019
Q3 		$5.46M Buy
48,842
+7,704
+19% +$858K 0.28% 84
2019
Q2 		$4.56M Buy
41,138
+555
+1% +$65.4K 0.25% 93
2019
Q1 		$5.27M Buy
40,583
+582
+1% +$70.8K 0.3% 83
2018
Q4 		$4.63M Sell
40,001
-887
-2% -$99.1K 0.3% 82
2018
Q3 		$4.39M Buy
40,888
+84
+0.2% +$8.4K 0.25% 91
2018
Q2 		$3.48M Buy
40,804
+527
+1% +$43.3K 0.21% 109
2018
Q1 		$3.12M Sell
40,277
-421
-1% -$33.9K 0.22% 108
2017
Q4 		$3.44M Sell
40,698
-3,185
-7% -$271K 0.23% 102
2017
Q3 		$3.75M Buy
43,883
+249
+0.6% +$20.4K 0.27% 95
2017
Q2 		$3.59M Sell
43,634
-1,156
-3% -$94.3K 0.27% 97
2017
Q1 		$3.77M Buy
44,790
+446
+1% +$35.7K 0.29% 93
2016
Q4 		$3.26M Sell
44,344
-51
-0.1% -$3.8K 0.26% 97
2016
Q3 		$3.56M Sell
44,395
-1,309
-3% -$105K 0.31% 82
2016
Q2 		$3.6M Buy
45,704
+1,618
+4% +$122K 0.32% 80
2016
Q1 		$3.17M Buy
44,086
+15,490
+54% +$1.17M 0.3% 87
2015
Q4 		$2.41M Buy
28,596
+4,497
+19% +$373K 0.22% 105
2015
Q3 		$2.02M Sell
24,099
-138
-0.6% -$11.7K 0.23% 103
2015
Q2 		$2.02M Sell
24,237
-680
-3% -$51.8K 0.21% 109
2015
Q1 		$1.81M Sell
24,917
-2,087
-8% -$149K 0.19% 124
2014
Q4 		$1.86M Sell
27,004
-6,644
-20% -$448K 0.2% 118
2014
Q3 		$2.18M Buy
33,648
+620
+2% +$39.3K 0.25% 95
2014
Q2 		$2.05M Buy
33,028
+3,406
+11% +$203K 0.24% 98
2014
Q1 		$1.74M Buy
29,622
+3,717
+14% +$207K 0.21% 110
2013
Q4 		$1.32M Buy
25,905
+2,757
+12% +$138K 0.17% 131
2013
Q3 		$1.17M Buy
23,148
+2,857
+14% +$150K 0.18% 131
2013
Q2 		$996K Buy
+20,291
New +$1.1M 0.16% 142

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Raymond James Trust's LLY Position: Q3 2024 in Review

Raymond James Trust increased its Eli Lilly (LLY) stake by 0.69% in Q3 2024, buying an estimated $216K and bringing the position to 34,943 shares worth $31M. The position accounts for 0.67% of the portfolio, ranked #30.

Raymond James Trust first reported a position in LLY in Q2 2013 and has held it in 46 quarters since. The position peaked at $31.4M in Q2 2024. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • Raymond James Trust held 34,943 shares of Eli Lilly worth $31M as of Q3 2024.
  • Raymond James Trust bought 240 Eli Lilly shares in Q3 2024, an estimated $216K.
  • Eli Lilly made up 0.67% of Raymond James Trust's portfolio in Q3 2024, its #30 holding.
  • Raymond James Trust first reported a position in Eli Lilly in Q2 2013 and has held it in 46 quarters since.
  • Raymond James Trust's Eli Lilly position peaked at $31.4M in Q2 2024.
  • 3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.